Rika Kihara

Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients

Rika Kihara, Yasunobu Nagata, Hitoshi Kiyoi et al. · Leukemia · 2014 · 228 citations

Hematological Malignancy, Prognostic Impacts, Genetics +13

A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia

Kosuke Tsuboi, Toshiya Yokozawa, Toru Sakura et al. · Leukemia Research · 2011 · 55 citations

Hematological Malignancy, Oncology, Medicine +7

Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study

Yasuhiko Harada, Yasunobu Nagata, Rika Kihara et al. · Leukemia Research · 2018 · 50 citations

Hematological Malignancy, Oncology, Cancer Epidemiology +14

Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study

Naomi Kawashima, Akimi Akashi, Yasunobu Nagata et al. · Annals of Hematology · 2018 · 25 citations

Hematological Malignancy, Jalsg Aml201 Study, Genetic Disorder +9

Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells

Naomi Kawashima, Yuichi Ishikawa, Jeong Hui Kim et al. · Nature Communications · 2022 · 22 citations · Full text